A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)

Status:
Completed

Trial end date:
2008-07-01

Target enrollment:

Participant gender:

This study will evaluate the safety and efficacy of 2 weeks of topical KD7040 versus placebo in the treatment of postherpetic neuralgia.

Phase 2

Kalypsys, Inc.